Free Trial

T. Rowe Price Investment Management Inc. Has $15.04 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background

T. Rowe Price Investment Management Inc. cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 32.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 792,515 shares of the medical instruments supplier's stock after selling 372,322 shares during the period. T. Rowe Price Investment Management Inc. owned 0.40% of DENTSPLY SIRONA worth $15,042,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $26,000. MassMutual Private Wealth & Trust FSB grew its position in DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after buying an additional 1,232 shares during the last quarter. UMB Bank n.a. increased its stake in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after buying an additional 1,568 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in DENTSPLY SIRONA by 513.3% in the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after purchasing an additional 3,706 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently weighed in on XRAY. StockNews.com downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Thirteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Hold" and an average target price of $21.25.

Read Our Latest Stock Report on XRAY

Insiders Place Their Bets

In other news, Director Gregory T. Lucier bought 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded up $0.03 during trading on Thursday, hitting $13.93. The stock had a trading volume of 3,200,700 shares, compared to its average volume of 2,977,454. The business has a fifty day moving average of $14.69 and a two-hundred day moving average of $18.04. The firm has a market cap of $2.78 billion, a P/E ratio of -6.73, a PEG ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $30.78.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.59%. DENTSPLY SIRONA's payout ratio is presently -14.07%.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines